ArticleInternal and emergency medicine2026
Characterization of pulmonary embolism events in patients with suspected pneumonia.
Article in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pneumonia and pulmonary embolism (PE) share similar clinical presentations, posing a significant diagnostic challenge. We investigated whether available diagnostic modalities could identify distinct characteristics in patients suspected of pneumonia later diagnosed with PE. Patients who underwent a CT pulmonary angiography (CTPA) scan on admission were retrospectively screened for suspected pneumonia, defined as a chest X-ray infiltrate accompanied by clinical or laboratory evidence of infection. Patients with COVID-19, pregnancy, and thrombophilia were excluded. Comorbidities, clinical presentation, electrocardiograms, laboratory tests, and outcomes were compared between patients with and without PE. Among 5,522 CTPA scans, 846 patients had suspected pneumonia. 106 (12.5%) had PE. Patients with PE had a higher rate of prior venous thromboembolism (14.2% vs. 7.7%, P = 0.03). However, other risk factors and baseline anticoagulation therapy were comparable between groups. Most clinical and laboratory parameters, including CRP and D-dimer levels, were similar, as were the Wells criteria and Geneva scores. New-onset atrial fibrillation was more frequent in PE patients (11.1% vs. 5.4%, P = 0.009). Prolonged expiration and wheezing were more common in those without PE (17.9% vs. 5.7%, P = 0.0015) and remained the only discriminative parameter in a multivariate analysis (OR = 0.29, 95%CI: 0.09-0.74, P = 0.021). Notably, the presence of PE did not impact mortality rates. PE is prevalent in patients with suspected pneumonia undergoing CTPA. Clinical presentation, laboratory findings, and commonly used diagnostic tools, including the Wells criteria and the Geneva score, perform poorly in this setting. These findings underscore the need for new diagnostic approaches.
Indexed as
Identifiers
42611387What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.